ArticleCurrent drug discovery technologies2026
Bioactive Furan Derivatives from
Article in Current drug discovery technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction
methodsStreptomyces sp. VITGV100 was grown in a nutrient broth supplemented with Magnesium and Iron elicitors. The secondary metabolites were analyzed for antioxidant activity via 2,2-diphenyl- 1-picrylhydrazyl radical scavenging activity, antimicrobial activity against
resultsMagnesium and Iron supplementation elevated the production of metabolites with antioxidant activity (90% scavenging, IC50 value 0.025 mg/ml) at 6 mg/ml of Magnesium, and antimicrobial properties show the highest inhibition zone of 23 mm against DISCUSSION: Magnesium and iron elicitation in Streptomyces sp. VITGV100 significantly enhances its antioxidant and antibacterial capabilities. Strong bioactivity and
conclusionMagnesium and Iron significantly improve the synthesis of bioactive compounds in Streptomyces sp. VITGV100, showing strong antioxidant and antimicrobial activities of these metabolites, combined with promising docking and ADMET profiles, shows promising therapeutic potential.
Indexed as
Identifiers
40926609What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.